Fig. 5
From: B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
High IL-1β expression but not TIB is correlated with poor outcomes in TNBC. Kaplan–Meyer survival analysis showing (a) shorter recurrence free survival (RFS, p < 0.001) and (b) overall survival (OS, p < 0.001) in patients with high tumor IL-1β expression.
